Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8

Vaccine
Akiko EtoYasuhiro Kanatani

Abstract

LC16m8 is a live, attenuated, cell-cultured smallpox vaccine that was developed and licensed in Japan in the 1970s, but was not used in the campaign to eradicate smallpox. In the early 2000s, the potential threat of bioterrorism led to reconsideration of the need for a smallpox vaccine. Subsequently, LC16m8 production was restarted in Japan in 2002, requiring re-evaluation of its safety and efficacy. Approximately 50,000 children in the 1970s and about 3500 healthy adults in the 2000s were vaccinated with LC16m8 in Japan, and 153 adults have been vaccinated with LC16m8 or Dryvax in phase I/II clinical trials in the USA. These studies confirmed the safety and efficacy of LC16m8, while several studies in animal models have shown that LC16m8 protects the host against viral challenge. The World Health Organization Strategic Advisory Group of Experts on Immunization recommended LC16m8, together with ACAM2000, as a stockpile vaccine in 2013. In addition, LC16m8 is expected to be a viable alternative to first-generation smallpox vaccines to prevent human monkeypox.

References

Dec 6, 2002·The Journal of General Virology·Geoffrey L SmithMansun Law
Aug 20, 2003·Nature Medicine·Erika HammarlundMark K Slifka
Jan 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·D Huw DaviesPhilip L Felgner
Mar 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Minoru KidokoroHisatoshi Shida
Apr 9, 2005·Clinical and Diagnostic Laboratory Immunology·Shuji HatakeyamaShigeru Morikawa
Sep 27, 2005·The Lancet Infectious Diseases·Isao Arita
Jul 11, 2006·Immunological Reviews·Ian J AmannaShane Crotty
Oct 21, 2006·Vaccine·Julie KennerMarc Gurwith
Apr 20, 2007·Proteomics·D Huw DaviesPhilip L Felgner
Jun 16, 2007·The Journal of Infectious Diseases·Steven J LawrenceSharon E Frey
Nov 21, 2008·Journal of Virology·Mohammed Rafii-El-Idrissi BenhniaShane Crotty
Nov 26, 2008·The American Journal of Medicine·Dennis D TaubDan L Longo
Mar 13, 2009·JAMA : the Journal of the American Medical Association·Tomoya SaitoNoriyuki Kuwabara
Sep 2, 2010·Proceedings of the National Academy of Sciences of the United States of America·Anne W RimoinJean-Jacques Muyembe
Sep 24, 2010·Future Microbiology·Clement A Meseda, Jerry P Weir
Dec 15, 2010·Journal of Virology·Johan LanttoAllan Jensen
Jan 5, 2011·Immunological Reviews·Bernard Moss
Apr 1, 2011·The Journal of Infectious Diseases·Shari N GordonGenoveffa Franchini
Jul 1, 2011·The Journal of General Virology·Benjamin F JohnsonGeoffrey L Smith
Sep 17, 2011·The Journal of Infectious Diseases·Jeffrey S KennedyRichard N Greenberg
Jul 6, 2014·Clinical and Vaccine Immunology : CVI·Hiroyuki YokoteSo Hashizume

❮ Previous
Next ❯

Citations

Feb 1, 2018·Vaccines·Sharon MelamedNir Paran
Jan 1, 2019·Voprosy virusologii·S N Shchelkunov, G A Shchelkunova
Aug 27, 2017·Viruses·Victoria A Olson, Sergei N Shchelkunov

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.